![David Walter Pignolet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Walter Pignolet
Chief Executive Officer at Juno Therapeutics GmbH
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Katherine Reynolds Kelly | F | 48 |
Celgene SRL (Belgium)
![]() Celgene SRL (Belgium) Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Celgene SRL (Belgium) is a Belgian company that engages in research and development on biotechnology. The company is based in Watermaal-Bosvoorde, Belgium. The CEOs are Katherine Reynolds Kelly, David Walter Pignolet. The company was founded in 2006.
Celgene Ltd.
![]() Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | 5 years |
Lothar Germeroth | M | - |
Juno Therapeutics GmbH
![]() Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | - |
Lynelle Baumgardner Hoch | F | 51 |
Celgene Ltd.
![]() Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | - |
Teresa Maria Vargas Quintas Campos | F | 49 |
Celgene Ltd.
![]() Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | - |
Paul Lacante | M | - |
Celgene SRL (Belgium)
![]() Celgene SRL (Belgium) Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Celgene SRL (Belgium) is a Belgian company that engages in research and development on biotechnology. The company is based in Watermaal-Bosvoorde, Belgium. The CEOs are Katherine Reynolds Kelly, David Walter Pignolet. The company was founded in 2006. | 3 years |
Stéphane Strebelle | M | - |
Celgene SRL (Belgium)
![]() Celgene SRL (Belgium) Miscellaneous Commercial ServicesCommercial Services Part of Bristol Myers Squibb Co., Celgene SRL (Belgium) is a Belgian company that engages in research and development on biotechnology. The company is based in Watermaal-Bosvoorde, Belgium. The CEOs are Katherine Reynolds Kelly, David Walter Pignolet. The company was founded in 2006. | 4 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Belgium | 3 | 50.00% |
United Kingdom | 3 | 50.00% |
Germany | 1 | 16.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Walter Pignolet
- Personal Network